CIPO Patents = 4

EPO Patents = 2

Forward Citations = 8

Loading Chart...

5 inventors (with patents filed for the assignee):

Robert Joseph Devita (3 out of 20 patents)

Daniel De Roulet (3 out of 3 patents)

Kevan M Shokat (2 out of 54 patents)

4. Nicholas T Hertz (2 out of 4 patents)

5. Robert J DeVita (2 out of 21 patents)

5 patents: Sort by Forward Citations

1. 11427588 - Compositions and methods for treating neurodegenerative diseases and cardiomyopathy (2022-08-30),

2. 11414419 - Substituted purines for the treatment of neurodegenerative and mitochondrial diseases (2022-08-16),

3. 10851109 - Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease (2020-12-01),

4. 10723737 - Compositions and methods for treating neurodegenerative diseases and cardiomyopathy (2020-07-28),

5. 10167286 - Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease (2019-01-01),

Mitokinin, Inc. is a biotechnology company focused on developing novel therapeutics for neurodegenerative diseases. Our innovative approach targets mitochondrial dysfunction to address conditions such as Parkinson's disease. Through cutting-edge research and partnerships, we aim to bring new treatments to patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

5 Patents

#755 in San Francisco, CA

#12,032 in California

#51,478 in US

San Francisco, CA, United States of America

Mitokinin, Inc.

Forward Citations = 8

5 inventors:

Robert Joseph Devita (3 out of 20 patents)

Daniel De Roulet (3 out of 3 patents)

Kevan M Shokat (2 out of 54 patents)

4. Nicholas T Hertz (2 out of 4 patents)

5. Robert J DeVita (2 out of 21 patents)

Please report any incorrect information to [email protected]

4 patents (CIPO):

Please report any incorrect information to [email protected]

2 patents (EPO):

Please report any incorrect information to [email protected]